HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Clinical effects and in vitro studies of trifluorothymidine combined with interferon-alpha for treatment of drug-resistant and -sensitive herpes simplex virus infections.

Abstract
Three AIDS patients with severe cutaneous herpes simplex virus (HSV) infection refractory to therapy with acyclovir and foscarnet (2 patients) were treated with a topical preparation of trifluorothymidine (TFT) and interferon-alpha. Complete healing of lesions occurred in 1 patient; a second had significant regression of the infected area. In the third, the lesion was stabilized twice after application of the preparation and reduced in size after a subsequent treatment. In vitro studies confirmed that isolates from these patients were acyclovir- or acyclovir/foscarnet-resistant. In addition, they revealed strong synergy between TFT and interferon-alpha for these isolates and for strains with wild-type drug sensitivity profiles. Topical TFT/interferon-alpha may be of benefit in the therapy of mucocutaneous HSV infections, especially when they are resistant to treatment with systemic antiviral agents.
AuthorsC J Birch, D P Tyssen, G Tachedjian, R Doherty, K Hayes, A Mijch, C R Lucas
JournalThe Journal of infectious diseases (J Infect Dis) Vol. 166 Issue 1 Pg. 108-12 (Jul 1992) ISSN: 0022-1899 [Print] United States
PMID1318909 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Antiviral Agents
  • Interferon Type I
  • Recombinant Proteins
  • Foscarnet
  • Phosphonoacetic Acid
  • Trifluridine
  • Acyclovir
Topics
  • Acquired Immunodeficiency Syndrome (complications)
  • Acyclovir (pharmacology, therapeutic use)
  • Adult
  • Antiviral Agents (pharmacology, therapeutic use)
  • Combined Modality Therapy
  • Cytopathogenic Effect, Viral (drug effects)
  • Dose-Response Relationship, Drug
  • Drug Resistance, Microbial
  • Female
  • Foscarnet
  • Herpes Simplex (complications, drug therapy, therapy)
  • Humans
  • Interferon Type I (pharmacology, therapeutic use)
  • Male
  • Phosphonoacetic Acid (analogs & derivatives, pharmacology, therapeutic use)
  • Recombinant Proteins
  • Recurrence
  • Simplexvirus (drug effects)
  • Trifluridine (pharmacology, therapeutic use)
  • Virus Replication (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: